Pathogenesis of redistribution of intrarenal blood flow in haemorrhagic hypotension.
D000109:Acetylcholine / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001345:Autoradiography; D001783:Blood Flow Velocity; D004285:Dogs; D007022:Hypotension / Q000150:complications* / Q000503:physiopathology; D007511:Ischemia / Q000209:etiology; D007668:Kidney / Q000098:blood supply* / Q000294:innervation; D007726:Krypton; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010208:Papaverine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011865:Radioisotope Dilution Technique; D011868:Radioisotopes; D012039:Regional Blood Flow / Q000187:drug effects; D012771:Shock, Hemorrhagic / Q000150:complications* / Q000503:physiopathology; D013564:Sympathetic Nervous System / Q000503:physiopathology*; D014666:Vasomotor System / Q000503:physiopathology; D014978:Xenon
D011868:Radioisotopes; D010643:Phenoxybenzamine; D000804:Angiotensin II; D014978:Xenon; D007726:Krypton; D010208:Papaverine; D000109:Acetylcholine; D009638:Norepinephrine; D010646:Phentolamine